首页 > 

https m fb777 pro

2025-01-25
PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.TOM UTLEY: The infuriating reason every Christmas at the Utleys begins with smiles... and ends with blood on the carpethttps m fb777 pro

White House National Security Communications Advisor John Kirby responds to more questions over the aerial systems on 'The Story.' White House National Security Communications Advisor John Kirby maintained that the government still lacks definitive answers regarding the nature of reported drone sightings as public frustration intensifies. "Many of the corroborated sightings have turned out to be piloted aircraft. I didn't say all of them, and what I said was those are the ones we were able to corroborate," Kirby said on " The Story ." "There certainly is ones that we have not been able to, and we don't know the answer to it, and I strongly recommend that for folks that are seeing these things and documenting them to share that as they can with the Department of Homeland Security and the FBI." DRONE MYSTERY: NEW JERSEY HOMEOWNERS THREATEN TO TAKE MATTERS INTO THEIR OWN HANDS IF GOVERNMENT DOESN'T ACT In a Wednesday letter to Biden, New Jersey Gov. Phil Murphy asked the president for more federal resources to address drone sightings, noting that the federal law limits the ability of state and local law enforcement to counter drones. "... it has become apparent that more resources are needed to fully understand what is behind this activity," Murphy wrote. "The continued reporting of UAS (unmanned aircraft systems) activity has raised more questions than answers and prompted an outcropping of conspiracy theories across social media and other platforms." A map showing drone sightings around New Jersey. Kirby addressed the possibility that the reported drone sightings could be linked to a private company, saying that they "could very well be" commercially developed drones of some kind. "Why don't we know? I wish I could tell you exactly why we don't have an answer for you here in the afternoon on the 13th of December," Kirby said. "But I can tell you that we are working on it very, very hard to know, because we want to answer those questions the same as those folks in New Jersey want answers to them." Kirby disclosed that there was an inter-agency conversation Friday morning about the topic. "We have now decided to employ some additional technology to New Jersey and some additional personnel to try to get a better sense of what these things are," he said. New Jersey State Assemblyman Paul Kanitra took a photo of what appears to be multiple drones hovering in the New Jersey sky on Thursday, Dec. 13. (Paul Kanitra / "Fox News @ Night") Monmouth County, N.J., Sheriff Shaun Golden urged officials to declare a state of emergency over the drone sightings, issuing a statement Wednesday evening. The release included a heat map showing the density of drones spotted across his county: A heat map indicating drone activity in Monmouth County, New Jersey. (Courtesy: Monmouth County Sheriff's Office) FOLLOW ALONG HERE FOR THE LATEST UPDATES ON THE NJ DRONE MYSTERY Rep. Chris Smith, R-N.J., whose district includes parts of Monmouth and Ocean Counties, recounted spending Monday night on a beach where he spoke with several individuals, including a U.S. Coast Guard commanding officer stationed in Barnegat Light. According to the commander, he said, a 47-foot Coast Guard vessel had been closely followed by more than a dozen drones the previous night. Monmouth and Burlington Counties are home to several military installations, including Naval Weapons Station Earle in Colts Neck and Joint Base McGuire-Dix-Lakehurst. On Thursday, Middletown, N.J., Mayor Tony Perry expressed his "concerns" to Fox News regarding the drone sightings near Naval Weapons Station Earle's waterfront site in his town, 14 miles north of the Colts Neck installation. CLICK HERE TO GET THE FOX NEWS APP "I'm not going to lie to you or to the American people, and I'm not going to say we know something when we don't," Kirby said. "We would never, ever stoop to think that an American citizen was crazy or nuts because of what they're seeing and what they're documenting. We're taking that imagery seriously, and we're doing the best we can to analyze it, and we encourage people to come forward if they have additional sightings and imagery." Joshua Comins is an associate editor for Fox News Digital. He covers media , politics , breaking news and current events. Story tips can be sent to joshua.comins@fox.com .

PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.

Ian Schieffelin came within two assists of a triple-double and Clemson handed Penn State its first loss with a 75-67 decision for the championship of the Sunshine Slam tournament Tuesday in Daytona Beach, Fla. Schieffelin finished with 18 points, 13 rebounds and eight assists for the Tigers (6-1), leading four players in double figures. Chase Hunter added 17 points, while Chauncey Wiggins scored 14 and reserve Del Jones chipped in 10 points. Clemson sank 9 of 19 3-pointers, converted 16 of 20 free throws and was able to limit the impact of the Nittany Lions' full-court pressure. The Tigers committed just 13 turnovers, helping them hold Penn State (6-1) to less than 85 points for the first time this year. Ace Baldwin starred in defeat with game highs of 20 points and 11 assists, while center Yanic Konan Niederhauser added 14 points. Nick Kern came off the bench to score 11 but Penn State was outscored 15-2 on the fast break and made just 4 of 18 attempts from 3-point range. Schieffelin came up big down the stretch, assisting on a 3-pointer by Jaeden Zackery with 6:04 left that made it 65-61. Then he made two foul shots and tossed in a jump hook from the lane to up the margin to 71-66 with 1:03 left. The big storyline going into this game was which team would be able to control the pace. Penn State came in averaging 96 ppg, while Clemson demonstrated its ability to enforce a slower tempo in March, advancing to a regional final in the NCAA Tournament. In the first 10 minutes of the game, the Tigers made the Nittany Lions play at a crawl, opening up a 17-10 advantage when Schieffelin converted a short hook in the lane. But Penn State answered with an 18-4 run over nearly six minutes, establishing a 28-21 lead when Kern shook free for a layup. Clemson rallied with nine straight points but the Nittany Lions had the last say as Baldwin converted a layup with 24 seconds left, cutting the Tigers' edge to 38-36 at halftime. --Field Level MediaCooper, Batcho lead Louisiana Tech past Richmond 65-62

Valero Energy Corp. stock outperforms competitors on strong trading day

Unique among ‘Person of the Year’ designees, Donald Trump gets a fact-check from Time magazinePORTLAND — Googly eyes have been appearing on sculptures around the central Oregon city of Bend, delighting many residents and sparking a viral sensation covered widely by news outlets and featured on a popular late-night talk show. On social media, the city shared photos of googly eyes on installations in the middle of roundabouts that make up its so-called “Roundabout Art Route.” One photo shows googly eyes placed on a sculpture of two deer, while another shows them attached to a sphere. It’s not yet known who has been putting them on the sculptures. “While the googly eyes placed on the various art pieces around town might give you a chuckle, it costs money to remove them with care to not damage the art,” the city said in its posts. The Facebook post received hundreds of comments, with many users saying they liked the googly eyes. “My daughter and I went past the flaming chicken today and shared the biggest laugh,” one user said, using a nickname for the “Phoenix Rising” sculpture. “We love the googly eyes. This town is getting to be so stuffy. Let’s have fun!” Another Facebook user wrote: “I think the googly eyes on the deer specifically are a great look, and they should stay that way.” Others said the city should focus on addressing more important issues, such as homelessness, instead of spending time and money on removing the googly eyes. Over the years, the city’s sculptures have been adorned with other seasonal decorations, including Santa hats, wreaths, leis. The city doesn’t remove those, and views the googly eyes differently because of the adhesive, Bend’s communications director, Rene Mitchell, told The Associated Press. “We really encourage our community to engage with the art and have fun. We just need to make sure that we can protect it and that it doesn’t get damaged,” she said. The post and its comments were covered by news outlets, and even made it on a segment of CBS’s “The Late Show with Stephen Colbert.” The city regrets that its post was misunderstood, Mitchell said. “There was no intent to be heavy-handed, and we certainly understand maybe how that was taken,” she said. “We own this large collection of public art and really want to bring awareness to the community that applying adhesives does harm the art. So as stewards of the collection, we wanted to share that on social media.” The city has so far spent $1,500 on removing googly eyes from seven of the eight sculptures impacted, Mitchell said, and has started treating some of the art pieces, which are made of different types of metal such as bronze and steel. The “Phoenix Rising” sculpture might need to be repainted entirely, she said. For some, the googly eyes — like the other holiday objects — provide a welcome boost of seasonal cheer. “I look forward to seeing the creativity of whoever it is that decorates the roundabouts during the holidays,” one social media commenter said. “Brings a smile to everyone to see silliness.”

Previous: fb777 com ang website
Next: fb777 download